Loading...
Loading...
All product recalls associated with Actavis Inc.
Total Recalls
51
Past Year
0
Class I (Serious)
0
Most Recent
Feb 2017
Data from FDA, USDA, CPSC, and NHTSA public records. Recall counts vary by company size, industry, and reporting practices. Always check official sources for current information.
Subpotent Drug
Failed Dissolution Specifications
Failed Capsule/Tablet Specifications: Actavis has received several complaint for clumping and breaking of capsules with some bottles showing popped out bottle bottom (round bottom) and creased labels from one distribution center.
Failed Capsule/Tablet Specifications: Actavis has received several complaint for clumping and breaking of capsules with some bottles showing popped out bottle bottom (round bottom) and creased labels from one distribution center.
Failed Capsule/Tablet Specifications: Actavis has received several complaint for clumping and breaking of capsules with some bottles showing popped out bottle bottom (round bottom) and creased labels from one distribution center.
Failed Tablet/Capsule Specifications: Presence of split or broken tablets.
Subpotent Drug
Subpotent Drug
Subpotent Drug.
Failed Tablet/Capsule Specifications: Recall due to complaints of split or broken tablets.
Failed Tablet/Capsule Specifications: Recall due to complaints of split or broken tablets.
Failed Tablet/Capsule Specifications: Complaints were received for significant tablet erosion for Alprazolam 1 mg.
Subpotent Drug: Drug potency was compromised during shipment.
Failed Dissolution Specifications: Product did not meet specification requirements for dissolution.
Failed Tablet/Capsule Specifications: Split tablets were found in the 12-month stability samples.
Labeling: Label Error On Declared Strength: Trelstar 11.25 mg labeled carton/kit contained a vial labeled as 3.75 mg instead of a vial being labeled as 11.25mg.
Failed Dissolution Specifications: Failed stability testing for dissolution test at 18 months.
Subpotent Drug: During routine stability testing one tablet was found with tablet weight below specification.
Failed Tablet/Capsule Specifications; partial tablet erosion resulting in tablet weights below specification in some tablets
Failed Dissolution Specifications: This recall is an extension of the recall initiated on 07/31/2013 for Bupropion HCl Extended-Release Tablets (XL) 300 mg, because another lot was shown to have similar failing results for dissolution at the 8-hour timepoint.